BeOne Medicines Ltd. (ONC) Return On Equity

Annual ROE:

-18.78%+3.48%(+15.63%)
December 31, 2024

Summary

  • As of today, ONC annual return on equity is -18.78%, with the most recent change of +3.48% (+15.63%) on December 31, 2024.
  • During the last 3 years, ONC annual ROE has risen by +10.41% (+35.66%).
  • ONC annual ROE is now -192.15% below its all-time high of 20.38%, reached on December 1, 2013.

Performance

ONC ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCprofitability metrics

Quarterly ROE:

-5.08%+6.45%(+55.94%)
June 30, 2025

Summary

  • As of today, ONC quarterly return on equity is -5.08%, with the most recent change of +6.45% (+55.94%) on June 30, 2025.
  • Over the past year, ONC quarterly ROE has increased by +9.61% (+65.42%).
  • ONC quarterly ROE is now at all-time high.

Performance

ONC Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherONCprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

ONC ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+15.6%+65.4%
3Y3 Years+35.7%+87.8%
5Y5 Years+73.0%+93.3%

ONC ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+50.7%at high+88.0%
5Y5-Yearat high+73.0%at high+92.0%
All-TimeAll-Time-192.2%+83.5%at high+94.5%

ONC ROE History

DateAnnualQuarterly
Jun 2025
-
-5.08%(+55.9%)
Mar 2025
-
-11.53%(+39.0%)
Dec 2024
-18.78%(+15.6%)
-18.91%(+23.3%)
Sep 2024
-
-24.64%(-67.7%)
Jun 2024
-
-14.69%(+30.3%)
Mar 2024
-
-21.07%(+6.1%)
Dec 2023
-22.26%(+41.6%)
-22.45%(+2.9%)
Sep 2023
-
-23.11%(+40.5%)
Jun 2023
-
-38.85%(+1.2%)
Mar 2023
-
-39.31%(-3.4%)
Dec 2022
-38.11%(-30.6%)
-
Dec 2022
-
-38.01%(+10.4%)
Sep 2022
-
-42.44%(-1.5%)
Jun 2022
-
-41.81%(+1.2%)
Mar 2022
-
-42.32%(-22.9%)
Dec 2021
-29.19%(+55.8%)
-34.43%(+0.5%)
Sep 2021
-
-34.62%(+3.4%)
Jun 2021
-
-35.83%(-7.5%)
Mar 2021
-
-33.32%(+39.6%)
Dec 2020
-66.03%
-55.12%(+13.1%)
Sep 2020
-
-63.46%(+16.3%)
Jun 2020
-
-75.82%(-9.6%)
DateAnnualQuarterly
Mar 2020
-
-69.18%(-5.1%)
Dec 2019
-69.59%(-25.8%)
-65.83%(-30.6%)
Sep 2019
-
-50.42%(-23.7%)
Jun 2019
-
-40.77%(+12.1%)
Mar 2019
-
-46.38%(+3.6%)
Dec 2018
-55.30%(-207.4%)
-48.10%(-14.3%)
Sep 2018
-
-42.09%(-48.0%)
Jun 2018
-
-28.44%(-30.3%)
Mar 2018
-
-21.82%(-11.3%)
Dec 2017
-17.99%(+67.8%)
-19.60%(-133.6%)
Sep 2017
-
-8.39%(+87.8%)
Jun 2017
-
-68.84%(-22.2%)
Mar 2017
-
-56.33%(-1.9%)
Dec 2016
-55.81%(+51.1%)
-55.29%(+16.2%)
Sep 2016
-
-65.95%(-1.8%)
Jun 2016
-
-64.77%(-4.0%)
Mar 2016
-
-62.27%(+15.5%)
Dec 2015
-114.10%(-58.5%)
-73.66%(-72.3%)
Sep 2015
-
-42.76%(+1.2%)
Jun 2015
-
-43.28%(+53.0%)
Mar 2015
-
-92.06%(-75.6%)
Dec 2014
-71.97%(-453.1%)
-52.43%
Dec 2013
20.38%
-

FAQ

  • What is BeOne Medicines Ltd. annual return on equity?
  • What is the all-time high annual ROE for BeOne Medicines Ltd.?
  • What is BeOne Medicines Ltd. annual ROE year-on-year change?
  • What is BeOne Medicines Ltd. quarterly return on equity?
  • What is the all-time high quarterly ROE for BeOne Medicines Ltd.?
  • What is BeOne Medicines Ltd. quarterly ROE year-on-year change?

What is BeOne Medicines Ltd. annual return on equity?

The current annual ROE of ONC is -18.78%

What is the all-time high annual ROE for BeOne Medicines Ltd.?

BeOne Medicines Ltd. all-time high annual return on equity is 20.38%

What is BeOne Medicines Ltd. annual ROE year-on-year change?

Over the past year, ONC annual return on equity has changed by +3.48% (+15.63%)

What is BeOne Medicines Ltd. quarterly return on equity?

The current quarterly ROE of ONC is -5.08%

What is the all-time high quarterly ROE for BeOne Medicines Ltd.?

BeOne Medicines Ltd. all-time high quarterly return on equity is -5.08%

What is BeOne Medicines Ltd. quarterly ROE year-on-year change?

Over the past year, ONC quarterly return on equity has changed by +9.61% (+65.42%)
On this page